JACKSONVILLE, FL / ACCESS Newswire / March 9, 2026 / GEE Group Inc. together with its subsidiaries (collectively referred to as the "Company," "GEE Group," "our" or " ...
VIS-101, purpose-designed to be best-in-class for retinal vascular diseases, is a tetravalent, dual VEGF-A X ANG-2 ...
VIS-101, purpose-designed to be best-in-class for retinal vascular diseases, is a tetravalent, dual VEGF-A X ANG-2 inhibitorTopline Phase 2a data show VIS-101 provides rapid, robust and durable treatm ...
VIS-101, purpose-designed to be a best-in-class dual VEGF-A/ANG-2 inhibitor, has the potential to provide more effective and ...
Intuitive Surgical ISRG has completed the acquisition of the da Vinci and Ion distribution business in Europe in a bid to ...
At MWC Barcelona 2026, the World Broadband Association (WBBA), together with global industry partners, released the Net5.5G Readiness Assessment and Certification white paper during the Broadband ...
Coherus Oncology, Inc. (CHRS) on Monday reported a loss of $37.6 million in its fourth quarter. The Redwood City, California-based company said it had a loss of 31 cents per share. Losses, adjusted ...
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. The company develops JADE101 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results